Notably, patients who did not respond to anti-TNFα therapy exhibited a mixed gene expression signature, with sustained elevated levels of IL1B, IL17A, and S100A8, while also showing significant modulation of other genes commonly upregulated in active CD, such as IL6 and IL23p19 [31]. The gene discussed is IL17A; the disease is Cowden disease.